We are live on ! Find out more
CGEM icon

Cullinan Oncology
CGEM

113 hedge funds and large institutions have $385M invested in Cullinan Oncology in 2023 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 45 increasing their positions, 24 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 24

64% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 14

12% more capital invested

Capital invested by funds: $344M → $385M (+$41M)

7% more funds holding

Funds holding: 106 → 113 (+7)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0.62% less ownership

Funds ownership: 88.93% → 88.31% (-0.62%)

12% less call options, than puts

Call options by funds: $97K | Put options by funds: $110K

Holders
113
Holders Change
+7
Holders Change %
+6.6%
% of All Funds
1.65%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
23
Increased
45
Reduced
24
Closed
14
Calls
$97K
Puts
$110K
Net Calls
-$13K
Net Calls Change
+$467K

Top Buyers

Rank Fund Capital Flow
1
BOCH
Blue Owl Capital Holdings
New York
+$30.3M
2
Morgan Stanley
Morgan Stanley
New York
+$13.8M
3
Deutsche Bank
Deutsche Bank
Germany
+$4.79M
4
Franklin Resources
Franklin Resources
California
+$3.46M
5
AAA
Affinity Asset Advisors
New York
+$2.66M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$10.4M
2
BC
Boxer Capital
California
-$9.72M
3
B
Braidwell
Connecticut
-$5.92M
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$5.51M
5
KCM
Kennedy Capital Management
Missouri
-$2.92M
Name Holding Trade Value Shares
Change 		Change in
Stake
TI
51
Trexquant Investment
Connecticut
$356K +$310K +34,955 New
NYLIM
52
New York Life Investment Management
New York
$344K -$9.26K -1,045 -3%
Marshall Wace
53
Marshall Wace
United Kingdom
$340K +$296K +33,374 New
ECM
54
ExodusPoint Capital Management
New York
$302K -$54.2K -6,122 -17%
California State Teachers Retirement System (CalSTRS)
55
California State Teachers Retirement System (CalSTRS)
California
$257K +$37.9K +4,280 +20%
JP Morgan Chase
56
JP Morgan Chase
New York
$257K +$7.79K +879 +4%
BC
57
Birchview Capital
Vermont
$256K – – –
PI
58
Putnam Investments
Massachusetts
$226K +$197K +22,210 New
T. Rowe Price Associates
59
T. Rowe Price Associates
Maryland
$225K +$67.5K +7,620 +53%
HSBC Holdings
60
HSBC Holdings
United Kingdom
$221K -$523 -59 -0.3%
Commonwealth Equity Services
61
Commonwealth Equity Services
Massachusetts
$214K – – –
Squarepoint
62
Squarepoint
New York
$204K +$178K +20,067 New
Susquehanna International Group
63
Susquehanna International Group
Pennsylvania
$203K +$62.2K +7,017 +54%
CIC
64
Cornercap Investment Counsel
Georgia
$191K +$1.13K +127 +0.7%
PCM
65
Prelude Capital Management
New York
$182K +$47K +5,300 +42%
A
66
AlphaQuest
New York
$179K +$156K +17,601 New
NIM
67
NEOS Investment Management
Connecticut
$162K +$141K +15,906 New
HCA
68
Harbor Capital Advisors
Illinois
$147K +$37.2K +4,197 +41%
SG Americas Securities
69
SG Americas Securities
New York
$147K +$14.1K +1,587 +12%
Mirae Asset Global Investments
70
Mirae Asset Global Investments
South Korea
$144K +$567 +64 +0.5%
ETC
71
Exchange Traded Concepts
Oklahoma
$143K +$31.6K +3,569 +34%
Legal & General Group
72
Legal & General Group
United Kingdom
$143K – – –
Jane Street
73
Jane Street
New York
$141K -$24.9K -2,812 -17%
MIM
74
MetLife Investment Management
New Jersey
$136K – – –
AC
75
Annandale Capital
Texas
$122K – – –
1 2
3
4 5

CGEM Hedge Fund Activity: Q4 2023 in Review

113 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Cullinan Oncology (CGEM) for Q4 2023, worth a combined $385M — up 12% from $344M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new CGEM positions and 14 closed out — a net gain of 9 holders — while 45 added to existing stakes and 24 trimmed.

The largest buyer was Blue Owl Capital Holdings, opening a new position worth an estimated $30.3M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $10.4M sold.

  • 113 institutional investors held Cullinan Oncology (CGEM) as of Q4 2023, up from 106 in Q3 2023.
  • Funds reported $385M of Cullinan Oncology stock for Q4 2023, up 12% quarter-over-quarter.
  • 23 funds opened new Cullinan Oncology positions in Q4 2023 and 14 closed out, a net change of +9 holders.
  • The largest Cullinan Oncology buyer in Q4 2023 was Blue Owl Capital Holdings, an estimated $30.3M added.
  • The largest Cullinan Oncology seller in Q4 2023 was Adage Capital Partners, an estimated $10.4M sold.

Based on aggregated 13F filings for Q4 2023.